EUVIMEDEUVIMED entdecken
Crossref

Radioactive Iodine in Intermediate-Risk Differentiated Thyroid Cancer: Bridging Evidence Gaps with Patient Decision Aids

Fernanda Vaisman

Clinical Thyroidology® · 01.03.2026 · 38 (3) · 92-94

DOI: 10.1177/23299711261436500 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Thyroidology®, online erschienen am 22.04.2026. Verfasst von Fernanda Vaisman. Die Arbeit nennt 6 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Vaisman, F. (2026). Radioactive Iodine in Intermediate-Risk Differentiated Thyroid Cancer: Bridging Evidence Gaps with Patient Decision Aids. Clinical Thyroidology®, 38(3), 92-94. https://doi.org/10.1177/23299711261436500

Vancouver

Vaisman F. Radioactive Iodine in Intermediate-Risk Differentiated Thyroid Cancer: Bridging Evidence Gaps with Patient Decision Aids. Clinical Thyroidology®. 2026;38(3):92-94. doi:10.1177/23299711261436500

BibTeX
@article{Vaisman2026,
  author = {Vaisman, Fernanda},
  title = {Radioactive Iodine in Intermediate-Risk Differentiated Thyroid Cancer: Bridging Evidence Gaps with Patient Decision Aids},
  journal = {Clinical Thyroidology®},
  year = {2026},
  volume = {38},
  number = {3},
  pages = {92--94},
  doi = {10.1177/23299711261436500}
}
Kostenlos starten →